The Australian Pesticides and Veterinary Medicines Authority (APVMA) is considering an application for approval of the new active constituent atinvicitinib for use in veterinary chemicals.
We invite relevant written comment from 10 March to 7 April 2026 on whether approval of the active constituent should be granted.
The APVMA is able to consider comments relating to the legislative grounds, including:
- Chemistry and manufacture
- Human health
- Environmental safety
- Target animal safety
For more information see page 13, in the APVMA Gazette No 5, Tuesday 10 March 2026.
Please lodge your submission with a public submission coversheet. The coversheet provides options for how your submission will be published.
Please note that submissions will be published on the APVMA’s website unless you have asked for the submission to remain confidential. Note that all APVMA documents are subject to the access provisions of the Freedom of Information Act 1982 and may be required to be released under that Act should a request for access be made.
Please send your written submission by email or post to:
Case Management
Australian Pesticides and Veterinary Medicines Authority
GPO Box 574
Canberra ACT 2601, Australia
Email: casemanagement@apvma.gov.au